Charles River (CRL) | Stock Overview & Key Data
Charles River Performance Comparison
Stock Range
Today's Range
Low: $148.13
High: $152.13
on August 8, 2025
52 Week Range
Low: $91.86
High: $230.02
on April 11, 2025
on November 6, 2024
All-Time High: $460.21 on September 20, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$7.4B
EPS
-1.29
P/E Ratio (TTM)
681.33
Forward P/E
14.47
P/B Ratio
2.18
PEG Ratio
14.47
Div. Yield
N/A
ROE
-1.81%
Beta
1.481
Debt to Equity
82.04
Financial Highlights
Profitability
Gross Margin
34.59%
Operating Margin
16.67%
Profit Margin
-1.66%
Returns and Earnings
Return on Assets (TTM)
4.31%
Return on Equity (TTM)
-1.81%
EBITDA
$796.1M
Net Income (TTM)
$-69.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$78.77
Quarterly Revenue Growth (YoY)
0.60%
Quarterly Earnings Growth (YoY)
-44.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Charles River CRL | 7.37B Mid-cap | -10.89% | -6.09% | 5.22% | -6.97% | -18.56% | -25.99% | -36.17% | -30.65% |
| Thermo Fisher TMO | 173.97B Large-cap | -0.50% | 8.11% | 12.16% | -16.67% | -11.84% | -22.72% | -23.62% | 11.35% |
| Danaher DHR | 143.61B Large-cap | 1.76% | -0.06% | 2.95% | -1.44% | -12.73% | -25.19% | -24.02% | 10.43% |
| Exact Sciences EXAS | 7.76B Mid-cap | -14.18% | -23.44% | -22.75% | -21.74% | -28.00% | -28.10% | -4.03% | -51.96% |
| Guardant Health GH | 6.76B Mid-cap | 30.93% | 6.71% | 30.11% | 22.14% | 70.70% | 87.00% | 0.09% | -36.54% |
| RadNet RDNT | 4.10B Mid-cap | -2.43% | -3.54% | -5.36% | -14.42% | -23.93% | -15.07% | 139.93% | 209.87% |
Ownership & Short Interest
Insider Ownership
1.01%
Institutional Ownership
113.94%
Shares Short
2M
Short Ratio
2.86
Short % of Shares Outstanding
5.42%
Average 10-Day Volume
989K
Average 90-Day Volume
877K
Charles River Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Charles River would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CRL's 52-week high and low?
- In the last 52 weeks, Charles River reached a high of $230.02 (on November 6, 2024) and a low of $91.86 (on April 11, 2025).
- What is the market cap and P/E ratio for CRL?
- Curious about Charles River's size and valuation? Its market capitalization stands at 7.37B. When it comes to valuation, the P/E ratio (trailing twelve months) is 681.33, and the forward P/E (looking ahead) is 14.47.
- Does CRL pay dividends? If so, what's the yield?
- As for dividends, Charles River isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Charles River's main competitors or similar companies to consider before investing?
When looking at Charles River, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Thermo Fisher
TMO173.97B Healthcare Diagnostics & Research -22.72% -23.62% Danaher
DHR143.61B Healthcare Diagnostics & Research -25.19% -24.02% Exact Sciences
EXAS7.76B Healthcare Diagnostics & Research -28.10% -4.03% Guardant Health
GH6.76B Healthcare Diagnostics & Research 87.00% 0.09% RadNet
RDNT4.10B Healthcare Diagnostics & Research -15.07% 139.93% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Charles River Laboratories International, Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Charles River's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -1.81%, the Debt to Equity ratio from the most recent quarter is 82.04, and its Gross Profit Margin stands at 34.59%.
- What is the recent revenue and earnings growth for CRL?
- Looking at Charles River's growth, its revenue over the trailing twelve months (TTM) was $4B. Compared to the same quarter last year (YoY), quarterly revenue grew by 0.60%, and quarterly earnings saw a YoY growth of -44.40%.
- How much of CRL stock is held by insiders and institutions?
- Wondering who owns Charles River stock? Company insiders (like executives and directors) hold about 1.01% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 113.94%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.